Internal Medicine, Endocrinology, Diabetes, & Metabolism · Overland Park, KS
NPI
1235163676
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5701 W 119th St, Suite 240
Overland Park, KS, 66209
Phone (913) 345-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$441K
35,133 services
Medicare patients, 2024
741
Average age 73
Drug cost, 2024
$4.0M
7,706 prescriptions
Company payments, 2025
$13K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Sokol was code J3111 (injection, romosozumab-aqqg, 1 mg), 26,985 times for 25 patients. In total Michael Sokol billed 35,133 services in 38 codes, and Medicare paid $441K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 26,985 | 25 | $8.50 | $229K |
| J0897 Injection, denosumab, 1 mg | Office | 6,420 | 65 | $20.69 | $133K |
| 99213 Office E&M - Established | Office | 474 | 321 | $57.45 | $27K |
| 99214 Office E&M - Established | Office | 345 | 237 | $84.55 | $29K |
| 77080 Standard X-ray | Facility | 279 | 279 | $8.74 | $2,438 |
| 96372 Injection Administration | Office | 263 | 86 | $9.48 | $2,492 |
| 99205 Office E&M - New | Office | 44 | 44 | $135.08 | $5,944 |
| 99215 Office E&M - Established | Office | 35 | 35 | $126.22 | $4,418 |
| 77081 Standard X-ray | Facility | 34 | 34 | $8.75 | $297 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 31 | 31 | $12.21 | $379 |
| 99212 Office E&M - Established | Office | 24 | 24 | $39.48 | $947 |
By year: 2022 $230K for 15,154 services; 2023 $376K for 32,179 services; 2024 $441K for 35,133 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael Sokol prescribed most often to Medicare patients was Levothyroxine Sodium, with 621 prescriptions and refills. In total Michael Sokol wrote 7,706 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 621 | 1,780 | 170 | $6,194 |
| Ozempic Semaglutide | 574 | 970 | 123 | $926K |
| Pioglitazone Hcl Generic | 365 | 1,064 | 110 | $4,695 |
| Mounjaro Tirzepatide | 258 | 419 | 55 | $444K |
| Metformin Hcl Generic | 249 | 737 | 75 | $2,293 |
| Tresiba Flextouch U-100 Insulin Degludec | 229 | 528 | 66 | $165K |
| Atorvastatin Calcium Generic | 226 | 635 | 70 | $2,253 |
| Synthroid Levothyroxine Sodium | 214 | 526 | 53 | $18K |
| Metformin Hcl Er Metformin Hcl | 184 | 514 | 57 | $2,492 |
| Glimepiride Generic | 177 | 506 | 50 | $1,497 |
| Trulicity Dulaglutide | 174 | 345 | 49 | $339K |
| Rosuvastatin Calcium Generic | 150 | 438 | 49 | $1,724 |
| Farxiga Dapagliflozin Propanediol | 143 | 340 | 37 | $190K |
| Jardiance Empagliflozin | 134 | 339 | 37 | $191K |
| Losartan Potassium Generic | 104 | 299 | 39 | $1,122 |
Brand drugs: 3,289 claims; generic drugs: 4,108 claims; opioid claims: 45.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Sokol $13K ($13K in general payments such as food, travel and fees) from 34 companies. The largest payer was Abbott Laboratories with $10K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.